An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy-Reference-Cited by-全球学者库

An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy

Published:2020-12-01 Issue:1 Volume:27 Page:255-266
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wang Yun,Cai Yan-yu,Herold Tobias^ORCID,Nie Run-cong,Zhang Yu,Gale Robert Peter^ORCID,Metzeler Klaus H.^ORCID,Zeng Yun,Wang Shun-qing,Pan Xue-yi,Yang Tong-hua,Wu Yuan-bin,Zhang Qing,Wuxiao Zhi-jun,Du Xin,Liang Zhi-wei,Su Yong-zhong,Xu Jing-bo,Wang Yong-qing,Liu Ze-lin,Wu Jian-wei,Zhang Xiong,Wu Bing-yi,Xiao Ruo-zhi,Wang San-bin,Li Jin-yuan,Chi Pei-dong,Zhang Qian-yi,Chen Si-liang,Qin Zhe-yuan,Zhang Xin-mei,Zhong Na,Hiddemann Wolfgang,Liu Qi-fa,Zhang Bei,Liang Yang^ORCID

Funder

Sun Yat-sen University

Guangdong Introducing Innovative and Entrepreneurial Teams

National Natural Science Foundation of China

Wilhelm-Sander-Stiftung

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid Leukemia;Frontiers in Cellular and Infection Microbiology;2024-01-11

2. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia;Inflammation Research;2024-01-10

3. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia;Annals of Hematology;2024-01-06

4. Tumor‐infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape;Cancer Reports;2023-11-28

5. Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies;CHINESE J CANCER RES;2023